Michael Rabinowitz Net Worth & Insider Trades

Michael Rabinowitz - Chief Commercial Officer, Oramed Pharmaceuticals Inc

As of January 4, 2023

What is Michael Rabinowitz's Net Worth?

The current estimated net worth of Oramed Pharmaceuticals Inc's Chief Commercial Officer, Michael Rabinowitz, is estimated to be about $465.66K . Michael Rabinowitz owns about 126,143 units of Oramed Pharmaceuticals Inc common stock. In the last 2 years at Oramed Pharmaceuticals Inc, Michael Rabinowitz has sold an estimated value of $290.92K worth.

What is Michael Rabinowitz's Past Insider Trading?

Michael Rabinowitz's largest sale order was 13,325 units , worth over $167.2K on January 4, 2023. In total, Michael Rabinowitz has made about 5 transactions over 2 years of their time at Oramed Pharmaceuticals Inc. Michael Rabinowitz usually trades in January and August, with the busiest year in 2021 and 2022.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Michael Rabinowitz

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Michael Rabinowitz's' Mailing Address?

  • Mailing address is 1185 Avenue of the Americas Third Floor New York NY 10036 NY

Oramed Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
Nadav Kidron 2020 $439,076 $220,582 $569,062 $539,131 $1,767,851
Nadav Kidron 2019 $419,460 $224,975 $398,910 $507,750 $1,551,095
Nadav Kidron 2018 $436,310 $148,795 $522,569 $442,326 $1,550,000
Miriam Kidron 2020 $305,840 $70,000 $299,506 $13,354 $688,700
Miriam Kidron 2019 $267,386 $123,149 $211,128 $14,503 $616,166
Miriam Kidron 2018 $273,595 $46,614 $253,204 $13,643 $587,056
Avraham Gabay 2020 $130,554 $15,591 - $44,912 $191,418
Avraham Gabay 2019 $32,122 - $73,928 $9,441 $115,491
Joshua Hexter 2020 $190,801 $12,169 $351,128 $54,735 $608,833
Joshua Hexter 2019 $52,848 - - $9,022 $61,870
Joshua Hexter 2018 $161,002 $26,895 $269,196 $50,505 $507,598
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1176309/000121390021039099/ea144766-def14a_oramedpharma.htm

What are Oramed Pharmaceuticals Inc's Past Insider Trades?

Oramed Pharmaceuticals Inc's most recent insider trade came on April 4, 2023 by Arie Mayer who bought 8,809 units worth $19.52K . In the last 15 years, insiders at Oramed Pharmaceuticals Inc have sold an estimated value of $12.78M and bought an estimated value of $6.61M worth of shares. Insider trading is most common in April and February, with the busiest year in 2022. The most active traders at the company are Nadav Kidron, President and CEO,  Miriam Kidron, Chief Scientific Officer,  and Leonard Sank, Director .

ORAMED PHARMACEUTICALS INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...